Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Drug Discovery | 10 | 2013 | 326 | 2.290 |
Why?
|
Drug Design | 11 | 2013 | 379 | 2.060 |
Why?
|
Computer-Aided Design | 4 | 2012 | 73 | 1.250 |
Why?
|
Computational Biology | 9 | 2013 | 1270 | 1.190 |
Why?
|
User-Computer Interface | 4 | 2013 | 286 | 1.100 |
Why?
|
Quantitative Structure-Activity Relationship | 7 | 2012 | 30 | 0.900 |
Why?
|
Proto-Oncogene Proteins c-akt | 7 | 2012 | 2062 | 0.830 |
Why?
|
Proteins | 5 | 2012 | 1953 | 0.810 |
Why?
|
Models, Molecular | 12 | 2013 | 1740 | 0.720 |
Why?
|
Lipid Bilayers | 1 | 2018 | 52 | 0.660 |
Why?
|
Glucuronides | 4 | 2013 | 44 | 0.650 |
Why?
|
Ligands | 6 | 2012 | 992 | 0.620 |
Why?
|
Phospholipids | 1 | 2018 | 177 | 0.620 |
Why?
|
Drug Delivery Systems | 3 | 2012 | 678 | 0.620 |
Why?
|
Databases, Pharmaceutical | 2 | 2013 | 7 | 0.560 |
Why?
|
Polypharmacy | 2 | 2013 | 57 | 0.520 |
Why?
|
Blood Proteins | 3 | 2011 | 292 | 0.520 |
Why?
|
Small Molecule Libraries | 3 | 2013 | 171 | 0.500 |
Why?
|
Drug Interactions | 2 | 2013 | 555 | 0.480 |
Why?
|
Nanoparticles | 1 | 2018 | 557 | 0.470 |
Why?
|
Thiamine Deficiency | 5 | 1997 | 10 | 0.440 |
Why?
|
Models, Chemical | 3 | 2013 | 186 | 0.430 |
Why?
|
Antineoplastic Agents | 12 | 2016 | 14288 | 0.430 |
Why?
|
Microsomes, Liver | 1 | 2013 | 116 | 0.430 |
Why?
|
Structure-Activity Relationship | 7 | 2013 | 935 | 0.430 |
Why?
|
Models, Theoretical | 2 | 2007 | 787 | 0.420 |
Why?
|
Prescription Drugs | 1 | 2013 | 64 | 0.410 |
Why?
|
Ether-A-Go-Go Potassium Channels | 1 | 2011 | 7 | 0.410 |
Why?
|
Molecular Docking Simulation | 1 | 2012 | 153 | 0.410 |
Why?
|
Biological Assay | 1 | 2013 | 176 | 0.400 |
Why?
|
ras Proteins | 1 | 2016 | 771 | 0.400 |
Why?
|
Serum Response Factor | 3 | 2007 | 49 | 0.390 |
Why?
|
Potassium Channel Blockers | 1 | 2011 | 110 | 0.390 |
Why?
|
Phosphoproteins | 3 | 2011 | 1151 | 0.380 |
Why?
|
Glucuronosyltransferase | 4 | 2012 | 108 | 0.380 |
Why?
|
Hepatocytes | 1 | 2013 | 346 | 0.380 |
Why?
|
Protein Binding | 12 | 2012 | 3438 | 0.360 |
Why?
|
Protein Kinase Inhibitors | 6 | 2013 | 4768 | 0.360 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2011 | 225 | 0.360 |
Why?
|
RNA | 2 | 2012 | 1010 | 0.340 |
Why?
|
HIV Protease | 1 | 2008 | 6 | 0.340 |
Why?
|
Binding Sites | 8 | 2012 | 2170 | 0.320 |
Why?
|
Wernicke Encephalopathy | 3 | 1997 | 12 | 0.310 |
Why?
|
High-Throughput Screening Assays | 4 | 2014 | 218 | 0.310 |
Why?
|
Sequence Analysis, Protein | 1 | 2008 | 81 | 0.310 |
Why?
|
Protein Conformation | 8 | 2012 | 1257 | 0.310 |
Why?
|
Drug-Related Side Effects and Adverse Reactions | 1 | 2013 | 596 | 0.300 |
Why?
|
Indolizines | 1 | 2007 | 46 | 0.300 |
Why?
|
Phenanthrenes | 1 | 2007 | 42 | 0.290 |
Why?
|
Alkaloids | 1 | 2007 | 79 | 0.290 |
Why?
|
Models, Biological | 5 | 2013 | 3242 | 0.290 |
Why?
|
Models, Statistical | 2 | 2013 | 1177 | 0.280 |
Why?
|
Database Management Systems | 1 | 2006 | 63 | 0.280 |
Why?
|
Pharmaceutical Preparations | 1 | 2008 | 148 | 0.280 |
Why?
|
Drug Screening Assays, Antitumor | 5 | 2013 | 566 | 0.280 |
Why?
|
Computer Simulation | 6 | 2014 | 1531 | 0.260 |
Why?
|
Crystallography, X-Ray | 4 | 2012 | 634 | 0.260 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2013 | 1759 | 0.250 |
Why?
|
Dimethyl Sulfoxide | 1 | 2005 | 51 | 0.250 |
Why?
|
Protein Structure, Tertiary | 6 | 2011 | 1487 | 0.250 |
Why?
|
Molecular Targeted Therapy | 2 | 2012 | 2334 | 0.230 |
Why?
|
Thermodynamics | 2 | 2012 | 196 | 0.200 |
Why?
|
MicroRNAs | 3 | 2014 | 2955 | 0.200 |
Why?
|
Phenols | 2 | 2012 | 107 | 0.190 |
Why?
|
Software | 1 | 2008 | 1326 | 0.190 |
Why?
|
Myosin Heavy Chains | 1 | 2001 | 129 | 0.190 |
Why?
|
Databases, Factual | 2 | 2007 | 2236 | 0.190 |
Why?
|
Neoplasms | 5 | 2016 | 15180 | 0.180 |
Why?
|
Protein Subunits | 2 | 2008 | 274 | 0.180 |
Why?
|
Thalamus | 3 | 1997 | 134 | 0.170 |
Why?
|
Entropy | 1 | 2018 | 38 | 0.170 |
Why?
|
Static Electricity | 1 | 2018 | 58 | 0.170 |
Why?
|
Poisson Distribution | 1 | 2018 | 92 | 0.170 |
Why?
|
Kinetics | 5 | 2013 | 2041 | 0.160 |
Why?
|
Muscles | 3 | 2005 | 416 | 0.160 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2013 | 507 | 0.160 |
Why?
|
Down-Regulation | 4 | 2014 | 2078 | 0.140 |
Why?
|
Biotransformation | 2 | 2013 | 93 | 0.140 |
Why?
|
Humans | 29 | 2016 | 262269 | 0.140 |
Why?
|
Drosophila | 1 | 2001 | 839 | 0.130 |
Why?
|
Catalysis | 3 | 2013 | 249 | 0.130 |
Why?
|
Diencephalon | 1 | 1995 | 14 | 0.130 |
Why?
|
Animals | 24 | 2014 | 59486 | 0.130 |
Why?
|
Databases, Protein | 2 | 2013 | 101 | 0.120 |
Why?
|
Flavonols | 2 | 2011 | 7 | 0.120 |
Why?
|
Dizocilpine Maleate | 1 | 1993 | 21 | 0.120 |
Why?
|
Alcoholism | 1 | 1997 | 308 | 0.120 |
Why?
|
Flavonoids | 2 | 2012 | 195 | 0.120 |
Why?
|
Cysteine | 2 | 2012 | 214 | 0.120 |
Why?
|
Rhodium | 1 | 2013 | 7 | 0.120 |
Why?
|
S-Phase Kinase-Associated Proteins | 1 | 2013 | 51 | 0.110 |
Why?
|
Oligonucleotides | 1 | 2014 | 227 | 0.110 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 1 | 2003 | 70 | 0.110 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2014 | 153 | 0.110 |
Why?
|
Mutant Proteins | 1 | 2014 | 234 | 0.110 |
Why?
|
Caco-2 Cells | 2 | 2012 | 161 | 0.110 |
Why?
|
Serum Albumin, Bovine | 1 | 2013 | 83 | 0.110 |
Why?
|
Cerebral Cortex | 1 | 1997 | 624 | 0.110 |
Why?
|
In Situ Hybridization | 3 | 2005 | 1033 | 0.110 |
Why?
|
Myoblasts, Cardiac | 1 | 2012 | 12 | 0.110 |
Why?
|
Proto-Oncogene Protein c-ets-2 | 1 | 2012 | 22 | 0.110 |
Why?
|
Metabolic Clearance Rate | 1 | 2013 | 232 | 0.110 |
Why?
|
Molecular Conformation | 1 | 2012 | 171 | 0.110 |
Why?
|
Amino Acids | 2 | 2004 | 727 | 0.110 |
Why?
|
Sulfotransferases | 1 | 2012 | 36 | 0.100 |
Why?
|
Flavones | 1 | 2011 | 15 | 0.100 |
Why?
|
Algorithms | 3 | 2012 | 3890 | 0.100 |
Why?
|
Chromones | 1 | 2011 | 120 | 0.100 |
Why?
|
Genes, Reporter | 4 | 2011 | 798 | 0.100 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2011 | 37 | 0.100 |
Why?
|
Cell Transdifferentiation | 1 | 2012 | 111 | 0.100 |
Why?
|
Drug Industry | 1 | 2012 | 88 | 0.100 |
Why?
|
Cyclohexanones | 1 | 2011 | 30 | 0.100 |
Why?
|
Transcription, Genetic | 3 | 2005 | 3127 | 0.100 |
Why?
|
Molecular Dynamics Simulation | 1 | 2012 | 130 | 0.100 |
Why?
|
Sulfonamides | 2 | 2011 | 1826 | 0.100 |
Why?
|
Inhibitory Concentration 50 | 1 | 2011 | 290 | 0.100 |
Why?
|
Protein Interaction Mapping | 1 | 2012 | 165 | 0.100 |
Why?
|
Transcription Factor RelA | 1 | 2011 | 184 | 0.100 |
Why?
|
Molecular Structure | 4 | 2012 | 524 | 0.090 |
Why?
|
Pyridones | 1 | 2013 | 350 | 0.090 |
Why?
|
Homeodomain Proteins | 3 | 2005 | 1139 | 0.090 |
Why?
|
I-kappa B Kinase | 1 | 2011 | 249 | 0.090 |
Why?
|
Gene Expression Regulation | 3 | 2007 | 4026 | 0.090 |
Why?
|
Thiadiazoles | 1 | 2010 | 47 | 0.090 |
Why?
|
Oncogene Protein v-akt | 1 | 2010 | 102 | 0.090 |
Why?
|
Polynucleotide Adenylyltransferase | 1 | 2009 | 13 | 0.090 |
Why?
|
ATP Synthetase Complexes | 1 | 2009 | 5 | 0.090 |
Why?
|
Cell Membrane Permeability | 1 | 2009 | 122 | 0.090 |
Why?
|
2-Chloroadenosine | 1 | 2009 | 37 | 0.080 |
Why?
|
Thiepins | 1 | 2008 | 2 | 0.080 |
Why?
|
Time Factors | 5 | 2012 | 12985 | 0.080 |
Why?
|
Genes, ras | 1 | 2012 | 667 | 0.080 |
Why?
|
Hippocampus | 2 | 1994 | 921 | 0.080 |
Why?
|
Myocardium | 3 | 2005 | 1295 | 0.080 |
Why?
|
Thymidine Kinase | 1 | 2009 | 193 | 0.080 |
Why?
|
Dimerization | 1 | 2008 | 303 | 0.080 |
Why?
|
Lac Operon | 2 | 2005 | 122 | 0.080 |
Why?
|
beta-Galactosidase | 2 | 2005 | 210 | 0.080 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2013 | 853 | 0.080 |
Why?
|
Protein Structure, Secondary | 1 | 2008 | 337 | 0.080 |
Why?
|
Seizures | 1 | 1993 | 986 | 0.080 |
Why?
|
Arrhythmias, Cardiac | 1 | 2011 | 478 | 0.080 |
Why?
|
Cost-Benefit Analysis | 1 | 2012 | 950 | 0.080 |
Why?
|
Rats, Sprague-Dawley | 4 | 1997 | 2073 | 0.080 |
Why?
|
Protein Isoforms | 3 | 2011 | 836 | 0.080 |
Why?
|
Peptide Fragments | 1 | 2003 | 1265 | 0.070 |
Why?
|
Adenosine Triphosphate | 1 | 2009 | 573 | 0.070 |
Why?
|
Adenosine | 1 | 2009 | 291 | 0.070 |
Why?
|
Organogenesis | 1 | 2007 | 118 | 0.070 |
Why?
|
Intestinal Mucosa | 1 | 2013 | 1082 | 0.070 |
Why?
|
Skin | 1 | 2012 | 1260 | 0.070 |
Why?
|
Pyrithiamine | 3 | 1995 | 3 | 0.070 |
Why?
|
Transgenes | 3 | 2005 | 556 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2012 | 3632 | 0.070 |
Why?
|
Transcription Factors | 5 | 2014 | 5253 | 0.070 |
Why?
|
Fibroblasts | 1 | 2012 | 1642 | 0.070 |
Why?
|
Myosins | 1 | 2005 | 95 | 0.070 |
Why?
|
Mesoderm | 2 | 2005 | 403 | 0.060 |
Why?
|
Neoplastic Stem Cells | 1 | 2013 | 1439 | 0.060 |
Why?
|
Nucleotides | 1 | 2005 | 163 | 0.060 |
Why?
|
Research Design | 1 | 2012 | 1562 | 0.060 |
Why?
|
Liver | 2 | 2011 | 2904 | 0.060 |
Why?
|
Mice | 11 | 2014 | 34391 | 0.060 |
Why?
|
Nerve Degeneration | 2 | 1997 | 149 | 0.060 |
Why?
|
Databases as Topic | 1 | 2005 | 134 | 0.060 |
Why?
|
Brain | 2 | 1997 | 4097 | 0.060 |
Why?
|
Genetic Vectors | 2 | 2012 | 1681 | 0.060 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 566 | 0.060 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2005 | 160 | 0.060 |
Why?
|
Amino Acid Motifs | 1 | 2005 | 394 | 0.060 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2005 | 606 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2013 | 4903 | 0.060 |
Why?
|
Enzyme Inhibitors | 2 | 2009 | 1879 | 0.060 |
Why?
|
Blotting, Western | 2 | 2012 | 3529 | 0.060 |
Why?
|
Luciferases | 1 | 2005 | 444 | 0.060 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2005 | 511 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2014 | 8882 | 0.060 |
Why?
|
Rats | 4 | 1997 | 6107 | 0.060 |
Why?
|
Heart | 2 | 2007 | 1227 | 0.060 |
Why?
|
Adenosine Triphosphatases | 1 | 2005 | 435 | 0.060 |
Why?
|
Enhancer Elements, Genetic | 1 | 2005 | 464 | 0.060 |
Why?
|
Learning | 1 | 2006 | 407 | 0.050 |
Why?
|
Cloning, Molecular | 1 | 2005 | 1208 | 0.050 |
Why?
|
DNA Mutational Analysis | 1 | 2008 | 2279 | 0.050 |
Why?
|
Xenopus Proteins | 1 | 2003 | 186 | 0.050 |
Why?
|
Medical Oncology | 1 | 2011 | 1424 | 0.050 |
Why?
|
Heterozygote | 1 | 2005 | 1015 | 0.050 |
Why?
|
Exons | 2 | 2005 | 1325 | 0.050 |
Why?
|
DNA | 2 | 2011 | 2683 | 0.050 |
Why?
|
Recombinant Proteins | 3 | 2012 | 2914 | 0.050 |
Why?
|
Pharyngeal Muscles | 1 | 2001 | 36 | 0.050 |
Why?
|
Embryonic and Fetal Development | 1 | 2001 | 204 | 0.050 |
Why?
|
Genome | 1 | 2005 | 678 | 0.050 |
Why?
|
Homeobox Protein Nkx-2.5 | 3 | 2005 | 27 | 0.050 |
Why?
|
Mice, Nude | 3 | 2014 | 4303 | 0.050 |
Why?
|
Biomarkers | 1 | 2011 | 5055 | 0.040 |
Why?
|
Transfection | 1 | 2005 | 2934 | 0.040 |
Why?
|
Cell Line, Tumor | 5 | 2014 | 14561 | 0.040 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 2 | 2014 | 619 | 0.040 |
Why?
|
Drosophila melanogaster | 1 | 2005 | 828 | 0.040 |
Why?
|
Chromatin | 1 | 2005 | 950 | 0.040 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2005 | 1485 | 0.040 |
Why?
|
Mutation | 2 | 2012 | 15167 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2005 | 2504 | 0.040 |
Why?
|
Glycolysis | 2 | 2013 | 523 | 0.040 |
Why?
|
Up-Regulation | 1 | 2005 | 2450 | 0.040 |
Why?
|
Oligonucleotides, Antisense | 2 | 2014 | 246 | 0.040 |
Why?
|
Signal Transduction | 3 | 2012 | 11972 | 0.040 |
Why?
|
Alternative Splicing | 1 | 2001 | 581 | 0.040 |
Why?
|
Cell Differentiation | 2 | 2007 | 4042 | 0.040 |
Why?
|
Mammillary Bodies | 1 | 1997 | 3 | 0.040 |
Why?
|
Microdialysis | 2 | 1994 | 50 | 0.040 |
Why?
|
Binding, Competitive | 2 | 2008 | 300 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2005 | 2022 | 0.040 |
Why?
|
Cell Line | 1 | 2005 | 5071 | 0.040 |
Why?
|
Embryo, Mammalian | 3 | 2005 | 739 | 0.040 |
Why?
|
Models, Genetic | 1 | 2001 | 1111 | 0.040 |
Why?
|
Atrophy | 1 | 1997 | 261 | 0.040 |
Why?
|
Cell Count | 1 | 1997 | 507 | 0.030 |
Why?
|
Gyrus Cinguli | 1 | 1997 | 140 | 0.030 |
Why?
|
Neural Pathways | 1 | 1997 | 297 | 0.030 |
Why?
|
Nervous System | 1 | 1996 | 165 | 0.030 |
Why?
|
Sequence Alignment | 2 | 2008 | 843 | 0.030 |
Why?
|
RNA, Messenger | 2 | 2005 | 6129 | 0.030 |
Why?
|
Elongin | 1 | 2014 | 9 | 0.030 |
Why?
|
Mice, SCID | 2 | 2009 | 1864 | 0.030 |
Why?
|
Histamine | 1 | 1994 | 53 | 0.030 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2012 | 5339 | 0.030 |
Why?
|
Chromosomes, Artificial, Bacterial | 2 | 2005 | 129 | 0.030 |
Why?
|
Thiamine | 1 | 1993 | 11 | 0.030 |
Why?
|
Male | 6 | 2013 | 123347 | 0.030 |
Why?
|
Cyclization | 1 | 2013 | 21 | 0.030 |
Why?
|
Extracellular Space | 1 | 1993 | 131 | 0.030 |
Why?
|
Circular Dichroism | 1 | 2003 | 112 | 0.030 |
Why?
|
Brain Mapping | 1 | 1997 | 648 | 0.030 |
Why?
|
Solutions | 1 | 2003 | 105 | 0.030 |
Why?
|
United States | 1 | 2010 | 15581 | 0.030 |
Why?
|
Mice, Transgenic | 3 | 2005 | 4125 | 0.030 |
Why?
|
Phloretin | 1 | 2012 | 5 | 0.030 |
Why?
|
Apigenin | 1 | 2012 | 12 | 0.030 |
Why?
|
Kaempferols | 1 | 2012 | 9 | 0.030 |
Why?
|
Actins | 2 | 2005 | 605 | 0.030 |
Why?
|
Flavanones | 1 | 2012 | 11 | 0.030 |
Why?
|
Arylsulfotransferase | 1 | 2012 | 18 | 0.030 |
Why?
|
Multienzyme Complexes | 1 | 2013 | 216 | 0.030 |
Why?
|
Genistein | 1 | 2012 | 73 | 0.030 |
Why?
|
Aspartic Acid | 1 | 2012 | 126 | 0.020 |
Why?
|
Reference Values | 1 | 1993 | 1096 | 0.020 |
Why?
|
Gene Knockout Techniques | 1 | 2012 | 277 | 0.020 |
Why?
|
Behavior, Animal | 1 | 1995 | 711 | 0.020 |
Why?
|
Valine | 1 | 2012 | 176 | 0.020 |
Why?
|
Lentivirus | 1 | 2012 | 168 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2012 | 552 | 0.020 |
Why?
|
Catalytic Domain | 1 | 2012 | 305 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2013 | 1077 | 0.020 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2014 | 590 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2013 | 7218 | 0.020 |
Why?
|
Amino Acid Sequence | 2 | 2008 | 4231 | 0.020 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2011 | 321 | 0.020 |
Why?
|
Biological Availability | 1 | 2011 | 225 | 0.020 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2011 | 188 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2012 | 391 | 0.020 |
Why?
|
DNA-Binding Proteins | 3 | 2014 | 4787 | 0.020 |
Why?
|
Analysis of Variance | 1 | 1995 | 2312 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2012 | 591 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2003 | 1001 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2003 | 625 | 0.020 |
Why?
|
Carcinogens | 1 | 2011 | 383 | 0.020 |
Why?
|
3-Phosphoinositide-Dependent Protein Kinases | 1 | 2010 | 41 | 0.020 |
Why?
|
Immunoblotting | 1 | 2012 | 882 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2013 | 1516 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2012 | 1063 | 0.020 |
Why?
|
Glycine | 1 | 2012 | 289 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2008 | 6062 | 0.020 |
Why?
|
Acute Disease | 1 | 1995 | 2431 | 0.020 |
Why?
|
Proteolysis | 1 | 2011 | 368 | 0.020 |
Why?
|
Halogenation | 1 | 2009 | 14 | 0.020 |
Why?
|
Poly A | 1 | 2009 | 88 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2012 | 374 | 0.020 |
Why?
|
Cyclooxygenase 2 | 1 | 2011 | 480 | 0.020 |
Why?
|
Surface Plasmon Resonance | 1 | 2009 | 104 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2012 | 11572 | 0.020 |
Why?
|
Hydrolysis | 1 | 2009 | 229 | 0.020 |
Why?
|
Genes, p53 | 1 | 2013 | 1093 | 0.020 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2012 | 666 | 0.020 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2010 | 283 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2014 | 1151 | 0.020 |
Why?
|
HT29 Cells | 1 | 2008 | 159 | 0.020 |
Why?
|
Stem Cells | 2 | 2005 | 1206 | 0.020 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2008 | 130 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2010 | 6925 | 0.020 |
Why?
|
Female | 4 | 2013 | 142305 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2011 | 1760 | 0.020 |
Why?
|
Gastrointestinal Tract | 1 | 2011 | 328 | 0.020 |
Why?
|
Cattle | 1 | 2009 | 783 | 0.020 |
Why?
|
Oxygen Consumption | 1 | 2009 | 398 | 0.020 |
Why?
|
Carcinogenesis | 1 | 2014 | 1027 | 0.020 |
Why?
|
DNA Primers | 1 | 2009 | 1395 | 0.020 |
Why?
|
Administration, Oral | 1 | 2011 | 1554 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2009 | 662 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2012 | 3189 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2011 | 1618 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2011 | 1540 | 0.020 |
Why?
|
Flight, Animal | 1 | 2005 | 12 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2012 | 5155 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2012 | 3022 | 0.020 |
Why?
|
Tongue | 1 | 2005 | 78 | 0.020 |
Why?
|
GATA4 Transcription Factor | 1 | 2005 | 48 | 0.020 |
Why?
|
Cell Survival | 1 | 2011 | 3042 | 0.020 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2005 | 252 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 1487 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2012 | 1541 | 0.020 |
Why?
|
Monosaccharides | 1 | 2004 | 24 | 0.020 |
Why?
|
Ions | 1 | 2004 | 54 | 0.020 |
Why?
|
In Situ Nick-End Labeling | 1 | 2005 | 446 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2011 | 1545 | 0.020 |
Why?
|
Protein Structure, Quaternary | 1 | 2004 | 138 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2011 | 3076 | 0.020 |
Why?
|
Apoptosis | 2 | 2011 | 7601 | 0.020 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2005 | 256 | 0.010 |
Why?
|
Oligosaccharides | 1 | 2004 | 110 | 0.010 |
Why?
|
Animals, Genetically Modified | 1 | 2005 | 405 | 0.010 |
Why?
|
Organ Specificity | 1 | 2005 | 694 | 0.010 |
Why?
|
Vitamins | 1 | 2004 | 156 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2011 | 3982 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2012 | 2633 | 0.010 |
Why?
|
Phosphorylation | 1 | 2011 | 4809 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2011 | 4945 | 0.010 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2005 | 289 | 0.010 |
Why?
|
Heart Atria | 1 | 2005 | 352 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2010 | 5378 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2005 | 766 | 0.010 |
Why?
|
Cell Lineage | 1 | 2005 | 663 | 0.010 |
Why?
|
Oligopeptides | 1 | 2004 | 425 | 0.010 |
Why?
|
GATA5 Transcription Factor | 1 | 2001 | 4 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2012 | 6223 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2008 | 1435 | 0.010 |
Why?
|
Culture Techniques | 1 | 2001 | 130 | 0.010 |
Why?
|
Endoderm | 1 | 2001 | 55 | 0.010 |
Why?
|
Motor Activity | 1 | 2005 | 692 | 0.010 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2010 | 3818 | 0.010 |
Why?
|
Chick Embryo | 1 | 2001 | 244 | 0.010 |
Why?
|
Amides | 1 | 2001 | 123 | 0.010 |
Why?
|
rho-Associated Kinases | 1 | 2001 | 85 | 0.010 |
Why?
|
Spleen | 1 | 2003 | 674 | 0.010 |
Why?
|
Heart Ventricles | 1 | 2005 | 849 | 0.010 |
Why?
|
Cell Polarity | 1 | 2001 | 209 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2005 | 1557 | 0.010 |
Why?
|
Stomach | 1 | 2003 | 387 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2012 | 10021 | 0.010 |
Why?
|
Myocytes, Cardiac | 1 | 2005 | 785 | 0.010 |
Why?
|
Gastric Mucosa | 1 | 2003 | 613 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2011 | 7241 | 0.010 |
Why?
|
Trans-Activators | 1 | 2005 | 1557 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2005 | 1277 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2005 | 5597 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2005 | 5672 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2001 | 1266 | 0.010 |
Why?
|
Methylhistidines | 1 | 1994 | 10 | 0.010 |
Why?
|
Histamine Release | 1 | 1994 | 15 | 0.010 |
Why?
|
Receptors, Glutamate | 1 | 1994 | 19 | 0.010 |
Why?
|
Gliosis | 1 | 1994 | 41 | 0.010 |
Why?
|
Pyridines | 1 | 2001 | 1243 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2005 | 7545 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2005 | 3317 | 0.010 |
Why?
|
Necrosis | 1 | 1994 | 583 | 0.010 |
Why?
|
Neuroglia | 1 | 1994 | 224 | 0.010 |
Why?
|
Glutamine | 1 | 1994 | 300 | 0.010 |
Why?
|
Glutamic Acid | 1 | 1994 | 309 | 0.010 |
Why?
|
Cell Death | 1 | 1994 | 672 | 0.010 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 1994 | 259 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2012 | 33028 | 0.010 |
Why?
|